ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1351	National Cancer Institute	Html	en	Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of osteosarcoma and malignant fibrous histiocytoma of bone.	high-grade osteosarcoma patients 0.629145 co-operative German-Austrian-Swiss osteosarcoma 0.55607 neoadjuvant cooperative osteosarcoma 0.624122 pediatric osteosarcoma 0.57965 locally recurrent osteosarcoma 0.5543 Primary high-grade osteosarcoma 0.612176 parosteal osteosarcoma 0.568181 conventional osteosarcoma 0.56726 High grade osteosarcoma 0.599621 cooperative osteosarcoma study 0.792783 nonmetastatic osteosarcoma 0.60813 german-austrian-swiss osteosarcoma study 0.647756 high-grade osteosarcoma 0.738641 craniofacial osteosarcoma 0.630712 conventional high-grade osteosarcoma 0.570688 patients 0.646684 radiation-associated craniofacial osteosarcoma 0.580431 European Osteosarcoma Intergroup 0.58771 osteosarcoma incidence rate 0.594537 neoadjuvant chemotherapy 0.670909 high-grade extremity osteosarcoma 0.5876 Extraskeletal osteosarcoma 0.568579 Craniofacial osteosarcoma Experience 0.589537 Group Osteosarcoma Study 0.569569 radiation-related osteosarcoma 0.565185	osteosarcoma skip metastases 0.57865 synchronous multifocal osteosarcoma 0.617106 Osteosarcoma Intergroup study 0.567726 et al. 0.76197 PUBMED Abstract 0.575849 unresectable high-grade osteosarcoma 0.562489 primary osteosarcoma 0.586929 periosteal osteosarcoma 0.560798 osteosarcoma study group 0.793978 recurrent osteosarcoma 0.571668 non-metastatic osteosarcoma 0.633808 multi-institutional osteosarcoma study 0.604239 extremity osteosarcoma 0.634474 metastatic osteosarcoma 0.602383 multiinstitutional osteosarcoma study 0.587612 Abstract 0.808529 Clin Oncol 0.842874 operable osteosarcoma 0.589711 cooperative german-austrian-swiss osteosarcoma 0.615008 primary tumor 0.561916 intermediate-grade osteosarcoma 0.59029 Oncology Group 0.566747 cancer 0.596697 osteosarcoma 0.959056	CLICK HERE
1694	National Cancer Institute	Html	en	Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®)–Patient Version	Childhood central nervous system (CNS) germ cell tumors form from germ cells (a type of cell that forms as a fetus develops and later becomes sperm in the testicles or eggs in the ovaries). Learn about the signs, tests to diagnose, and treatment of pediatric germ cell tumors in the brain in this expert-reviewed summary.	tumor marker levels 0.3628 cancer treatment 0.421684 Cell Tumors Treatment 0.421872 tumor marker 0.418943 blood tumor marker 0.368072 tumor marker tests 0.401497 germ cell tumor 0.574325 chemotherapy 0.377281 following PDQ summaries 0.365055 PDQ cancer information 0.426073 clinical trials 0.64034 Pediatric Treatment Editorial 0.365107 cancer information summary 0.398144 clinical trial 0.507274 childhood cns 0.519486 tumor markers 0.382879 CNS germ cell 0.581589 Extracranial Germ Cell 0.410121 different types 0.371541 NCI PDQ cancer 0.369493 radiation therapy 0.586685 Treatment Editorial Board 0.36802 Cord Tumors Treatment 0.393052 late effects 0.370411 treatment 0.581174	cancer cells 0.438925 treatment clinical trial 0.368062 PDQ Pediatric Treatment 0.363419 nervous system germ 0.412082 treatment clinical trials 0.389618 National Cancer Institute 0.397655 diagnose childhood CNS 0.382168 spinal cord 0.499499 tumor cells 0.386305 Germ cells tumors 0.441556 new treatment 0.423148 high tumor marker 0.363373 childhood cancer information 0.366666 external radiation therapy 0.366121 brain 0.390174 PDQ summary 0.396735 germ cell tumors 0.941151 cells 0.445231 cancer clinical trials 0.367524 stem cell rescue 0.36994 cancer 0.582086 standard treatment 0.367712 tumor marker level 0.399336 spinal cord tumors 0.390737	CLICK HERE
3562	Administration for Children and Families	Html	en	National Domestic Violence Hotline funded	U.S. Department of Health and Human Services’ Administration for Children and Families (ACF) has announced the award of $4.	feedback 0.653075 website 0.623074	page 0.938356	CLICK HERE
3596	Administration for Children and Families	Html	en	HHS releases additional $300 million to help families, seniors heat homes	Nearly $300 million is now available from HHS’ Administration for Children and Families (ACF) to help Americans who may struggle to heat their homes during frigid temperatures this winter.	feedback 0.653075 website 0.623074	page 0.938356	CLICK HERE
3657	Administration for Children and Families	Html	en	ACF and IHS award $21 million to support Tribal family violence victims and organizations	October marks National Domestic Violence Prevention Month and today, the U.S. Department of Health and Human Services Administration for Children and Families (ACF) and Indian Health Service (IHS) are announcing the award of nearly $21 million to support tribal domestic violence victims and organizations in American Indian and Alaska Native communities across the nation.	feedback 0.653075 website 0.623074	page 0.938356	CLICK HERE
3660	Administration for Children and Families	Html	en	Health Profession Opportunity Grants Awarded	The HPOG program is designed to match careers in a growing field with people who are eager to fill them.  HPOG participants get onto a career pathway with the help of higher education and supportive services. Some of the most common education programs prepare students to become nurses, medical assistants, home health aides and pharmacy technicians.	feedback 0.653075 website 0.623074	page 0.938356	CLICK HERE
3851	National Cancer Institute	Html	en	Treating Cancer without Harming the Heart	Researchers from the fields of oncology and cardiology are working to find ways to prevent, manage, and possibly even reverse the cardiovascular side effects of certain cancer therapies.	childhood cancers 0.722954 cardiovascular changes 0.633513 cancer treatment-related cardiotoxicity 0.773654 ischemic heart disease 0.641571 research 0.740587 task force 0.629922 childhood cancer increases 0.668587 cardiac health 0.652664 heart problems 0.663961 heart failure 0.684862 risk factors 0.812151 certain cardiac functions 0.66508 Community Oncology Research 0.635145 ischemic cardiac disease 0.673041 breast cancer patients 0.750275 adult survivors 0.677672 heart 0.763054 breast cancer trial 0.667286 Prevention Trials Research 0.631942 radiation therapy 0.716677 childhood cancer 0.74187 cancer treatments 0.731665 childhood cancer treatments 0.686861 study 0.637136	community oncology 0.686779 cancer treatment—chemotherapy agents 0.673113 cardiac side effects 0.698632 Anderson Cancer Center 0.750363 early cardiac dysfunction 0.678902 new research strategies 0.65852 trastuzumab-related cardiac events 0.724465 Dana-Farber Cancer Institute 0.652906 Community Oncology Cardiotoxicity 0.640076 cardiac risk factors 0.767014 subsequent research agendas 0.636051 cardiac adverse effects 0.710556 MD Anderson Cancer 0.75179 cardiac arrhythmia 0.64223 NCI Community Oncology 0.685131 NCI-supported cardiotoxicity studies 0.649029 breast cancer 0.957268 treatment-induced cardiac disease 0.677462 NCI community-based oncology 0.638369 breast cancer treatments 0.671567 Vanderbilt-Ingram Cancer Center 0.655353 cancer clinical trials 0.814235 underlying cardiovascular risk 0.658241 cardiovascular problems 0.640023	CLICK HERE
4331	Administration for Children and Families	Html	en	ACF at 25: Impacting People, Affecting Change, Empowering Families	The Administration for Children and Families celebrates its 25th Anniversary.	feedback 0.653075 website 0.623074	page 0.938356	CLICK HERE
15686	Administration for Children and Families	Html	en	Training the Medical Community to Identify Trafficking Victims	Health professionals play a critical role in combatting human trafficking.	feedback 0.653075 website 0.623074	page 0.938356	CLICK HERE
16851	National Cancer Institute	Html	es	Sulfato de hidracina (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso del sulfato de hidracina como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Centro Nacional 0.533358 determinados efectos 0.530508 New Hampshire Avenue 0.523784 siguientes aspectos 0.523737 Drug Administration 0.514799 patients with weight 0.533925 NCI Best Case 0.549835 diagnosed non-small-cell lung 0.536234 Grosvenor M 0.517103 datos bibliográficos pubmed 0.525622 siguientes preguntas 0.515807 Heber D 0.517667 siguientes riesgos 0.519241 Instituto Nacional 0.7207 Su JQ 0.518581 Salud Complementaria 0.556196 Visuals Online 0.516984 siguientes resultados 0.521312 curso estudios 0.529991 complementarias revisa 0.524603	Clin Oncol 0.521025 Physician Data Query 0.597613 Goldberg RM 0.517983 PDQ Sulfato 0.709455 Estados Unidos 0.833671 Chlebowski RT 0.553534 breakdown measured 0.519564 libre uso 0.517176 compañía farmacéutica 0.520309 página manejo 0.515736 ¿El tratamiento 0.532073 Bulcavage L 0.518136 patients with 0.551924 siguientes datos 0.520348 ¿Los beneficios 0.514828 juntos cam 0.514239 Funcionamiento motor 0.518326 Tayek JA 0.519355 Series Program 0.514501 medicina complementaria 0.982503	CLICK HERE